A Case of Pulmonary Mycobacterium abscessus Subspecies abscessus Disease That Showed a Discrepancy Between the Genotype and Phenotype of Clarithromycin Resistance

Yusuke Yamaba; Osamu Takakuwa; Manami Saito; Daisuke Kawae; Misuzu Yoshihara; Yuta Mori; Eiji Kunii; Yutaka Ito; Shiomi Yoshida; Kenji Akita

doi:10.2169/internalmedicine.2391-18

この記事には本公開記事があります。本公開記事を参照してください。
引用する場合も本公開記事を引用してください。

A Case of Pulmonary Mycobacterium abscessus Subspecies abscessus Disease That Showed a Discrepancy Between the Genotype and Phenotype of Clarithromycin Resistance

Yusuke Yamaba, Osamu Takakuwa, Manami Saito, Daisuke Kawae, Misuzu Yoshihara, Yuta Mori, Eiji Kunii, Yutaka Ito, Shiomi Yoshida, Kenji Akita

著者情報

キーワード: Mycobacterium abscessus, inducible resistance, erm (41)

ジャーナルオープンアクセス早期公開

論文ID: 2391-18

DOI https://doi.org/10.2169/internalmedicine.2391-18

この記事には本公開記事があります。

The final version of this article is now available: Vol. 58 (2019), No. 18 pp. 2675-2678

詳細

抄録

Mycobacterium abscessus subspecies abscessus is major subspecies in the M. abscessus complex and is usually refractory to standard antibiotherapy. Genetic tracing of erm (41) T28 is a mechanism for monitoring macrolide resistance. We treated a patient with a pulmonary infection caused by M. abscessus subsp. abscessus with the erm (41) T28 polymorphism, which was susceptible to clarithromycin, and his clinical treatment course was good. The identification of the M. abscessus complex genotype is important, but clinical confirmation of clarithromycin susceptibility is also needed to plan individual treatment strategies.

責任著者(Corresponding author)

J-STAGEへの登録はこちら（無料）